Ocugen, Inc.
NASDAQ:OCGN
1.14 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.036 | 2.488 | 0 | 0.043 | 0 | 0 | 0 | 0 | 0 | 0 | 0.008 | 0.026 |
| Cost of Revenue
| 0.704 | 1.073 | 0.589 | 0.006 | 0.061 | 0.05 | 1.534 | 1.673 | 1.614 | 0 | 0 | 0 |
| Gross Profit
| 5.332 | 1.415 | -0.589 | 0.036 | -0.061 | -0.05 | -1.534 | -1.673 | -1.614 | 0 | 0.008 | 0.026 |
| Gross Profit Ratio
| 0.883 | 0.569 | 0 | 0.851 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Reseach & Development Expenses
| 39.573 | 49.757 | 35.108 | 6.353 | 8.086 | 15.634 | 15.566 | 21.577 | 23.243 | 25.856 | 11.946 | 11.941 |
| General & Administrative Expenses
| 31.994 | 35.111 | 22.92 | 7.974 | 6.077 | 10.204 | 9.384 | 8.53 | 8.266 | 6.746 | 4.847 | 3.053 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 31.994 | 35.111 | 22.92 | 7.974 | 6.077 | 10.204 | 9.384 | 8.53 | 8.266 | 6.746 | 4.847 | 3.053 |
| Other Expenses
| 2.453 | 3.517 | -0.31 | 0.183 | -0.785 | 1.434 | -0.116 | -0.248 | -0.072 | 0.013 | -0.052 | -0.03 |
| Operating Expenses
| 71.567 | 84.868 | 58.028 | 14.327 | 14.163 | 25.838 | 24.95 | 30.107 | 31.509 | 32.602 | 16.793 | 14.994 |
| Operating Income
| -65.531 | -84.868 | -58.028 | -21.285 | -14.163 | -30.108 | -24.95 | -30.307 | -31.819 | -32.662 | -16.845 | -14.968 |
| Operating Income Ratio
| -10.857 | -34.111 | 0 | -499.407 | 0 | 0 | 0 | 0 | 0 | 0 | -2,105.625 | -575.692 |
| Total Other Income Expenses Net
| 2.453 | 3.517 | -0.389 | -0.537 | -6.08 | 17.765 | -1.598 | 17.059 | -0.382 | 9.96 | -8.927 | -1.169 |
| Income Before Tax
| -63.078 | -81.351 | -58.417 | -21.822 | -20.243 | -8.643 | -26.414 | -16.208 | -32.024 | -22.793 | -25.712 | -16.935 |
| Income Before Tax Ratio
| -10.45 | -32.697 | 0 | -512.012 | 0 | 0 | 0 | 0 | 0 | 0 | -3,214 | -651.346 |
| Income Tax Expense
| 0.536 | -3.997 | -0.052 | 0.802 | 0.983 | -15.761 | -0.186 | -15.82 | -1.171 | -10.522 | 8.875 | 1.937 |
| Net Income
| -63.078 | -77.834 | -58.365 | -22.623 | -21.226 | -8.643 | -26.414 | -16.208 | -32.024 | -22.793 | -25.712 | -16.935 |
| Net Income Ratio
| -10.45 | -31.284 | 0 | -530.818 | 0 | 0 | 0 | 0 | 0 | 0 | -3,214 | -651.346 |
| EPS
| -0.26 | -0.36 | -0.3 | -0.2 | -1.53 | -13.98 | -69.91 | -68.21 | -145.22 | -891.47 | -120.93 | -79.65 |
| EPS Diluted
| -0.26 | -0.36 | -0.3 | -0.2 | -1.53 | -13.98 | -69.91 | -67.58 | -145.22 | -891.47 | -120.93 | -79.65 |
| EBITDA
| -64.827 | -84.868 | -58.338 | -14.101 | -14.886 | -41.719 | -23.468 | -47.414 | -31.199 | -42.549 | -7.344 | -13.191 |
| EBITDA Ratio
| -10.74 | -34.111 | 0 | -330.854 | 0 | 0 | 0 | 0 | 0 | 0 | -918 | -507.346 |